Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Centre for Rehabilitation Research in Oxford (RRIO) led by Professor Sallie Lamb of NDORMS has been awarded £2 million by the National Institute for Health Research (NIHR) to look at improving the management of lower back pain in older people.

The Centre for Rehabilitation Research in Oxford (RRIO) lead by Professor Sallie Lamb of NDORMS has been awarded £2 million by the National Institute for Health Research (NIHR) to look at improving the management of lower back pain in older people.

Lower back pain is now recognised as the leading disabling condition in the world, with over 70% of people suffering with it in their lifetime. Older people in particular are at higher risk of having the most serious forms of lower back pain, leading to mobility decline and falls, as well as frailty and loss of independence – a key concern for this age group.

Despite this, lower back pain in older people is often ignored, missed or mismanaged in primary care. Both patients and their GPs may dismiss treatment for lower back pain, instead accepting it as part of ageing and prioritising the treatment of other health conditions. In addition, although there is a large amount of research on back pain, older people are often excluded from these studies.

The BOOST programme of research (Better Outcomes for Older People with Spinal Trouble) will help primary health care clinicians, patients and their carers recognise when to prioritize the treatment of back pain , and to explore and hopefully counter prejudices held by older people and clinicians.  It will also evaluate a physiotherapy programme for people with neurogenic claudication, a condition arising from ageing changes within the spine, which is common in older people and can severely limit their ability to walk and stand.  

Dr Esther Williamson, NDORMS Research Fellow and project lead says: "Remaining independent is the key concern for older people. Through this work we want to develop evidence based treatment strategies as well as an improved understanding of prognosis and greater knowledge about back pain in older people. By developing effective treatments we hope to reduce pain but also have an impact on broader health outcomes, helping older people to remain active and independent and preventing falls and frailty."

If you’d like to find out more about this study or be involved, please contact Esther and the BOOST research team at BOOST@ndorms.ox.ac.uk

 

Similar stories

Immunology preprint reviews launched in Nature Reviews Immunology

Kennedy Main Research

The Oxford-Mount Sinai (OxMS) Preprint Journal Club has partnered with Nature Reviews Immunology to launch a monthly Preprint Watch column.

Living reviews launched by Oxford and Cardiff in the wake of COVID-19 research

Kennedy Main Research

In a combined effort to help COVID-19 researchers the University of Oxford and Cardiff University have launched a series of “living reviews” in Oxford University Press’s new open access journal “Oxford Open Immunology”.

3D imaging reveals the role of blood vessels in hormone production

Kennedy Main Research

New research from the Kusumbe Group at the Kennedy Institute has shown a direct correlation between age-related decline in capillary and artery numbers and hormone production in the endocrine system.

Patients set to benefit from new guidelines on Artificial Intelligence health solutions

CSM Main

Patients could benefit from a faster and more effective introduction of artificial intelligence (AI) innovations to diagnose and treat disease – thanks to the first international standards for reporting of clinical trials for AI.

Grant towards OHDSI Global Research on COVID-19 treatments

Main Statistics and epidemiology

An international cohort of OHDSI collaborators obtain a grant from the COVID-19 Therapeutics Accelerator to lead an effort to compare the effectiveness of treatments, including corticosteroids such as dexamethasone, under current evaluation for COVID-19 across an international observational data network.

Six-month outcomes after treatment for COVID-19 on intensive care units in England

CSM Main

Researchers at the University of Oxford are investigating the long-term health outcomes for patients who have been treated for severe COVID-19 disease in intensive care.